Full-length transcriptomic analysis in murine and human heart reveals diversity of PGC-1α promoters and isoforms regulated distinctly in myocardial ischemia and obesity.


Journal

BMC biology
ISSN: 1741-7007
Titre abrégé: BMC Biol
Pays: England
ID NLM: 101190720

Informations de publication

Date de publication:
30 07 2022
Historique:
received: 24 01 2022
accepted: 23 06 2022
entrez: 30 7 2022
pubmed: 31 7 2022
medline: 3 8 2022
Statut: epublish

Résumé

Peroxisome proliferator-activated receptor gamma coactivator-1 alpha (PGC-1α) acts as a transcriptional coactivator and regulates mitochondrial function. Various isoforms are generated by alternative splicing and differentially regulated promoters. In the heart, total PGC-1α deficiency knockout leads to dilatative cardiomyopathy, but knowledge on the complexity of cardiac isoform expression of PGC-1α remains sparse. Thus, this study aims to generate a reliable dataset on cardiac isoform expression pattern by long-read mRNA sequencing, followed by investigation of differential regulation of PGC-1α isoforms under metabolic and ischemic stress, using high-fat-high-sucrose-diet-induced obesity and a murine model of myocardial infarction. Murine (C57Bl/6J) or human heart tissue (obtained during LVAD-surgery) was used for long-read mRNA sequencing, resulting in full-length transcriptomes including 58,000 mRNA isoforms with 99% sequence accuracy. Automatic bioinformatic analysis as well as manual similarity search against exonic sequences leads to identification of putative coding PGC-1α isoforms, validated by PCR and Sanger sequencing. Thereby, 12 novel transcripts generated by hitherto unknown splicing events were detected. In addition, we postulate a novel promoter with homologous and strongly conserved sequence in human heart. High-fat diet as well as ischemia/reperfusion (I/R) injury transiently reduced cardiac expression of PGC-1α isoforms, with the most pronounced effect in the infarcted area. Recovery of PGC-1α-isoform expression was even more decelerated when I/R was performed in diet-induced obese mice. We deciphered for the first time a complete full-length transcriptome of the murine and human heart, identifying novel putative PGC-1α coding transcripts including a novel promoter. These transcripts are differentially regulated in I/R and obesity suggesting transcriptional regulation and alternative splicing that may modulate PGC-1α function in the injured and metabolically challenged heart.

Sections du résumé

BACKGROUND
Peroxisome proliferator-activated receptor gamma coactivator-1 alpha (PGC-1α) acts as a transcriptional coactivator and regulates mitochondrial function. Various isoforms are generated by alternative splicing and differentially regulated promoters. In the heart, total PGC-1α deficiency knockout leads to dilatative cardiomyopathy, but knowledge on the complexity of cardiac isoform expression of PGC-1α remains sparse. Thus, this study aims to generate a reliable dataset on cardiac isoform expression pattern by long-read mRNA sequencing, followed by investigation of differential regulation of PGC-1α isoforms under metabolic and ischemic stress, using high-fat-high-sucrose-diet-induced obesity and a murine model of myocardial infarction.
RESULTS
Murine (C57Bl/6J) or human heart tissue (obtained during LVAD-surgery) was used for long-read mRNA sequencing, resulting in full-length transcriptomes including 58,000 mRNA isoforms with 99% sequence accuracy. Automatic bioinformatic analysis as well as manual similarity search against exonic sequences leads to identification of putative coding PGC-1α isoforms, validated by PCR and Sanger sequencing. Thereby, 12 novel transcripts generated by hitherto unknown splicing events were detected. In addition, we postulate a novel promoter with homologous and strongly conserved sequence in human heart. High-fat diet as well as ischemia/reperfusion (I/R) injury transiently reduced cardiac expression of PGC-1α isoforms, with the most pronounced effect in the infarcted area. Recovery of PGC-1α-isoform expression was even more decelerated when I/R was performed in diet-induced obese mice.
CONCLUSIONS
We deciphered for the first time a complete full-length transcriptome of the murine and human heart, identifying novel putative PGC-1α coding transcripts including a novel promoter. These transcripts are differentially regulated in I/R and obesity suggesting transcriptional regulation and alternative splicing that may modulate PGC-1α function in the injured and metabolically challenged heart.

Identifiants

pubmed: 35907957
doi: 10.1186/s12915-022-01360-w
pii: 10.1186/s12915-022-01360-w
pmc: PMC9338484
doi:

Substances chimiques

Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha 0
Protein Isoforms 0
RNA, Messenger 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

169

Informations de copyright

© 2022. The Author(s).

Références

Trends Cardiovasc Med. 2012 May;22(4):98-105
pubmed: 22939990
J Biotechnol. 2022 Jan 10;343:1-6
pubmed: 34756973
Diabetologia. 2015 Sep;58(9):1969-77
pubmed: 26109214
Trends Endocrinol Metab. 2012 Feb;23(2):90-7
pubmed: 22047951
Nucleic Acids Res. 2018 Jan 4;46(D1):D493-D496
pubmed: 29040681
Physiol Genomics. 2006 May 16;25(3):364-74
pubmed: 16554547
J Biol Chem. 2018 Mar 30;293(13):4953
pubmed: 29602880
Nucleic Acids Res. 2017 Jan 4;45(D1):D200-D203
pubmed: 27899674
J Biol Chem. 2009 Dec 11;284(50):35165-76
pubmed: 19846556
J Biol Chem. 2014 Mar 28;289(13):8810-7
pubmed: 24505137
Mol Ther. 2019 Jan 2;27(1):46-58
pubmed: 30528085
Cardiovasc Diabetol. 2018 Aug 2;17(1):111
pubmed: 30071860
J Biol Chem. 2011 Dec 16;286(50):42923-36
pubmed: 22009745
Am J Hypertens. 2018 Jan 12;31(2):240-246
pubmed: 29140431
Cell Rep. 2015 Mar 10;10(9):1572-1584
pubmed: 25753422
Genome Res. 2018 Jul;28(7):1096
pubmed: 29967126
Transcription. 2015;6(3):41-50
pubmed: 26226151
Semin Cell Dev Biol. 2012 Jun;23(4):381-8
pubmed: 22285815
Circ Res. 2010 Oct 1;107(7):825-38
pubmed: 20884884
Nat Commun. 2021 Jul 9;12(1):4203
pubmed: 34244519
Cardiovasc Res. 2019 Jan 1;115(1):107-118
pubmed: 29931052
J Biol Chem. 2008 Jul 18;283(29):20220-30
pubmed: 18441008
J Mol Cell Cardiol. 2012 Mar;52(3):701-10
pubmed: 22080103
Biochem J. 2007 May 1;403(3):511-8
pubmed: 17284167
Biochem Biophys Res Commun. 2015 Aug 28;464(3):692-7
pubmed: 26159922
Nucleic Acids Res. 2019 Jan 8;47(D1):D351-D360
pubmed: 30398656
Eur J Nutr. 2018 Aug;57(5):1891-1900
pubmed: 28540526
J Biol Chem. 2016 Jul 15;291(29):15169-84
pubmed: 27231350
Mol Metab. 2020 Apr;34:72-84
pubmed: 32180561
Am J Physiol Endocrinol Metab. 2014 Jan 15;306(2):E157-67
pubmed: 24280126
Clin Exp Pharmacol Physiol. 2002 Apr;29(4):339-45
pubmed: 11985547
Nature. 2008 Feb 21;451(7181):1008-12
pubmed: 18288196
J Physiol. 2003 Sep 1;551(Pt 2):491-501
pubmed: 12824444
Curr Opin Lipidol. 2007 Oct;18(5):508-14
pubmed: 17885420
J Am Heart Assoc. 2020 Feb 4;9(3):e015502
pubmed: 32013699
Cell. 2012 Dec 7;151(6):1319-31
pubmed: 23217713
Bioinformatics. 2013 Jan 1;29(1):15-21
pubmed: 23104886
J Physiol. 2016 Dec 1;594(23):7049-7071
pubmed: 27716916
Biochem Biophys Res Commun. 2017 Feb 19;483(4):1166-1177
pubmed: 27514452
Diabetes. 2018 Dec;67(12):2695-2702
pubmed: 30257974
J Bioinform Comput Biol. 2010 Oct;8(5):885-900
pubmed: 20981893
Trends Endocrinol Metab. 2015 Jun;26(6):305-14
pubmed: 25934582
Mol Metab. 2018 Jan;7:12-22
pubmed: 29157948
Curr Issues Mol Biol. 2018;28:29-46
pubmed: 29388552
Eur J Appl Physiol. 2020 Nov;120(11):2487-2493
pubmed: 32840695
Methods Mol Biol. 2016;1418:283-334
pubmed: 27008021
Adv Drug Deliv Rev. 2010 Oct 30;62(13):1218-26
pubmed: 20723571
Korean J Intern Med. 2017 May;32(3):404-421
pubmed: 28415836
Bioinformatics. 2018 Sep 15;34(18):3094-3100
pubmed: 29750242
Genes Dev. 2005 Jun 15;19(12):1466-73
pubmed: 15964996
Cell Rep. 2021 Nov 16;37(7):110022
pubmed: 34788620
Skelet Muscle. 2020 May 6;10(1):14
pubmed: 32375875

Auteurs

Daniel Oehler (D)

Division of Cardiology, Pulmonology, and Vascular Medicine, Medical Faculty, Heinrich-Heine University, Moorenstr. 5, 40225, Düsseldorf, Germany. Daniel.Oehler@med.uni-duesseldorf.de.
Cardiovascular Research Institute Düsseldorf (CARID), Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany. Daniel.Oehler@med.uni-duesseldorf.de.

André Spychala (A)

Department of Cardiovascular Physiology, Heinrich-Heine University Düsseldorf, Düsseldorf, Germany.

Axel Gödecke (A)

Cardiovascular Research Institute Düsseldorf (CARID), Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany.
Department of Cardiovascular Physiology, Heinrich-Heine University Düsseldorf, Düsseldorf, Germany.

Alexander Lang (A)

Division of Cardiology, Pulmonology, and Vascular Medicine, Medical Faculty, Heinrich-Heine University, Moorenstr. 5, 40225, Düsseldorf, Germany.
Cardiovascular Research Institute Düsseldorf (CARID), Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany.

Norbert Gerdes (N)

Division of Cardiology, Pulmonology, and Vascular Medicine, Medical Faculty, Heinrich-Heine University, Moorenstr. 5, 40225, Düsseldorf, Germany.
Cardiovascular Research Institute Düsseldorf (CARID), Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany.

Jorge Ruas (J)

Molecular and Cellular Exercise Physiology, Department of Physiology and Pharmacology, Karolinska Institutet, SE-17177, Stockholm, Sweden.

Malte Kelm (M)

Division of Cardiology, Pulmonology, and Vascular Medicine, Medical Faculty, Heinrich-Heine University, Moorenstr. 5, 40225, Düsseldorf, Germany.
Cardiovascular Research Institute Düsseldorf (CARID), Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany.

Julia Szendroedi (J)

Joint Heidelberg-IDC Translational Diabetes Program, Internal Medicine, Heidelberg University Hospital, Heidelberg, Germany.
German Center for Diabetes Research, Neuherberg, Germany.

Ralf Westenfeld (R)

Division of Cardiology, Pulmonology, and Vascular Medicine, Medical Faculty, Heinrich-Heine University, Moorenstr. 5, 40225, Düsseldorf, Germany. Ralf.Westenfeld@med.uni-duesseldorf.de.
Cardiovascular Research Institute Düsseldorf (CARID), Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany. Ralf.Westenfeld@med.uni-duesseldorf.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH